Alcon AG traded at 66.14 this Friday June 24th, increasing 1.40 or 2.16 percent since the previous trading session. Looking back, over the last four weeks, Alcon AG gained 5.24 percent. Over the last 12 months, its price rose by 2.45 percent. Looking ahead, we forecast Alcon AG to be priced at 62.24 by the end of this quarter and at 57.67 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
66.14
Daily Change
2.16%
Yearly
2.45%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AstraZeneca 10,776.00 396.00 3.82% 26.79%
Bayer 57.79 -0.75 -1.28% 11.59%
Essilor 146.55 5.00 3.53% -5.77%
Fresenius Medical Care 47.09 0.93 2.01% -32.77%
Fresenius 28.10 0.54 1.96% -36.83%
GRIFOLS 18.53 -0.09 -0.46% -18.23%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Lonza Group 512.80 24.80 5.08% -22.42%
Merck 164.80 8.70 5.57% 4.01%
Novartis 80.60 2.37 3.03% -4.80%
Philips 20.61 1.06 5.43% -51.39%
Roche Holding 318.80 12.50 4.08% -7.54%
Sanofi 100.56 4.81 5.02% 13.95%
Smith & Nephew PLC 1,165.00 15.50 1.35% -25.65%
UCB 80.94 -0.74 -0.91% -6.71%

Indexes Price Day Year
CH20 10823 369.81 3.54% -9.81%

Alcon AG
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.